Teva Pharmaceutical Industries Ltd. (NYSE,TASE:TEVA) has signed an agreement to sell its Sellersville, Pennsylvania facility to G&W Laboratories, Inc., salvaging 280 employees’ jobs and further streamlining its own operations by reducing excess manufacturing capacity. The sale is part of the Company’s previously announced ...
Read More »Teva Receives FDA Approval For First Waterless Nasal Aerosol for Allergic Rhinitis In Young Children טבע הודיעה על קבלת אישור לפורמולציה במינון נמוך יותר של תרסיס לאף לילדים
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) has announced that the U.S. Food and Drug Administration (FDA) approved QNASL® (beclomethasone dipropionate) 40 mcg for treatment of seasonal and year-round nasal symptoms associated with allergic rhinitis (AR) in children 4-11 years of age. An ...
Read More »Teva Pharmaceutical (NYSE:TEVA) CFO: No New Plans for Job Cuts סמנכ"ל כספים תרופות טבע: לא צפויים עוד פיטורי עובדים
Employees of Teva Pharmaceutical Industries Ltd. can rest easy. According to Chief Financial Officer Eyal Desheh, there are no new plans to cut jobs in the near future. This should come as a relief after the massive 5,000 employee layoff ...
Read More »Teva Pharmaceutical Industries (NYSE:TEVA; TASE:TEVA) Recalls Parkinson’s Disease Medication טבע תעשיות פרמצבטיות מבצעת ריקול בתרופה למחלת פרקינסון
Teva Pharmaceutical Industries Ltd. is issuing a Class II recall of one lot (3,881 bottles) of carbidopa/levodopa 25 mg/100 mg, a generic drug used to treat Parkinson’s disease, due to the potential for “superpotent” tablets. The lot in question was manufactured ...
Read More »